Literature DB >> 10867201

Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia.

J S Meyer1, G Rauch, R A Rauch, A Haque.   

Abstract

Putative risk factors accelerating mild cognitive decline and dementia were correlated with repeated measures of cerebral atrophy, CT, densitometry, perfusions, and cognitive testing among neurologically and cognitively normative aging volunteers. A total of 224 normative subjects at increased risk for cognitive decline were admitted to the study. Mean entry age was 59.5 +/- 15.8 years. Mean follow-up is 5.8 +/- 3.3 years. At follow-up, 22 developed mild cognitive impairment (41 CCSE >/= -3), 19 became demented-8 with Vascular type (VAD), 11 with Alzheimer's type (DAT)-and 183 remain cognitively unchanged. Cerebral atrophy, tissue densities, and perfusions were measured by Xe-CT. After age 60, cerebral atrophy, ventricular enlargement, and polio- and leuko-araiosis geometrically increased as perfusions declined. Risk factors accelerating perfusional decline, cerebral atrophy, polio-araiosis, and leuko-araiosis were: transient ischemic attacks (TIAs), hypertension, smoking, hyperlipidemia, and male gender. At age 71.5 +/- 11.9, mild cognitive impairment began accelerated by TIAs, hypertension and heart disease. Leuko-araiosis began before cognitive decline. TIAs, hypertension, and hyperlipidemia correlated with VAD. Excessive cortical perfusional decrease, gray and white matter hypodensities, and cerebral atrophy correlate with cognitive decline.

Entities:  

Mesh:

Year:  2000        PMID: 10867201     DOI: 10.1016/s0197-4580(00)00136-6

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  51 in total

1.  Thickness of the human cerebral cortex is associated with metrics of cerebrovascular health in a normative sample of community dwelling older adults.

Authors:  Elizabeth C Leritz; David H Salat; Victoria J Williams; David M Schnyer; James L Rudolph; Lewis Lipsitz; Bruce Fischl; Regina E McGlinchey; William P Milberg
Journal:  Neuroimage       Date:  2010-10-28       Impact factor: 6.556

2.  Diastolic blood pressure levels and ischemic stroke incidence in older adults with white matter lesions.

Authors:  Shoshana Reshef; Linda Fried; Norman Beauchamp; Daniel Scharfstein; Daniel Reshef; Steven Goodman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-10-28       Impact factor: 6.053

Review 3.  Diabetes and brain damage: more (or less) than meets the eye?

Authors:  Christopher M Ryan
Journal:  Diabetologia       Date:  2006-10       Impact factor: 10.122

4.  The bidirectional association between reduced cerebral blood flow and brain atrophy in the general population.

Authors:  Hazel I Zonneveld; Elizabeth A Loehrer; Albert Hofman; Wiro J Niessen; Aad van der Lugt; Gabriel P Krestin; M Arfan Ikram; Meike W Vernooij
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-08       Impact factor: 6.200

5.  Exploratory analysis of cerebral oxygen reserves during sleep onset in older and younger adults.

Authors:  Barbara W Carlson; Virginia J Neelon; John R Carlson; Marilyn Hartman; Sunil Dogra
Journal:  J Am Geriatr Soc       Date:  2008-04-01       Impact factor: 5.562

6.  Aging, vascular risk, and cognition: blood glucose, pulse pressure, and cognitive performance in healthy adults.

Authors:  Cheryl L Dahle; Bradley S Jacobs; Naftali Raz
Journal:  Psychol Aging       Date:  2009-03

Review 7.  The effects of hypertension on the cerebral circulation.

Authors:  Paulo W Pires; Carla M Dams Ramos; Nusrat Matin; Anne M Dorrance
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

Review 8.  Linking vascular disorders and Alzheimer's disease: potential involvement of BACE1.

Authors:  Sarah L Cole; Robert Vassar
Journal:  Neurobiol Aging       Date:  2008-03-04       Impact factor: 4.673

9.  Diet and age interactions with regards to cholesterol regulation and brain pathogenesis.

Authors:  Romina M Uranga; Jeffrey N Keller
Journal:  Curr Gerontol Geriatr Res       Date:  2010-04-11

10.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.